Skip to main content

Table 2 Types of severe adverse effects registered in DRC after ivermectin treatment, between 2003 and 2017

From: Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo

Types of severe adverse effects

N (%)

Non-neurological SAE (N = 314)

 

 Asthenia

65 (20.7)

 Vertigos

20 (6.4)

 Itching

15 (4.8)

 Localised or generalised oedema

9 (2.9)

 Severe headache

235 (74.8)

 Myalgia

201 (64.0)

 Diarrhoea + vomiting

88 (28.0)

 Arthralgia

197 (62.7)

Neurological SAE (N = 631)

 Coma

594 (94.1)

 Paralysis

13 (2.1)

 Palpebral SCH

245 (38.8)

 Speech disabilities

188 (29.8)

 Motor deficit

476 (75.4)

  1. SAE = severe adverse effects, N = number, SCH = subconjunctival haemorrhage